Yamo Pharmaceuticals

0 followers

‌

Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.

Industries

Biotechnology, Pharmaceutical

Headquarters

New York, United States

Employees

1-10

Links

Org chart

Chuck Bramlage

Chief Executive Officer

Chuck Bramlage

Collapse

Eugene Prahin

Chief Financial Officer

Tracy Fischer

Senior Vice President – Regulatory Affairs & Quality

Uyen Nguyen

Vice President Of Clinical Research Operations

Brian Cahill

Chief Financial Officer

Teams

This company has no teams yet

Offices

Similar companies

AbbVie

201 followers

Novavax

10 followers

Shionogi

6 followers

Amgen

235 followers

PTC Therapeutics

11 followers

Bristol-Myers Squibb

207 followers

Thermo Fisher Scientific

180 followers

Gilead Sciences

136 followers

Regeneron

104 followers

Vertex Pharmaceuticals

66 followers

Agilent Technologies

72 followers

Explore companies

��������